CVS Health Expands Board with Glenview Capital Deal

The healthcare giant adds four new directors following strategic discussions with activist investor Glenview Capital.

CVS Health has increased its board to 16 members by adding four new directors from Glenview Capital Management.
The new board members include Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, bringing diverse experience to the company.
Glenview Capital, holding a 1% stake in CVS, has been advocating for changes to enhance the company's financial and operational performance.
CVS's new CEO, David Joyner, focuses on improving the company's integrated business model and addressing cost challenges in its Aetna insurance arm.
CVS shares saw a 3% increase following the announcement, reflecting investor optimism about the board expansion and future strategy.